SPONSOR
Yongquan Shi
Total Trials
2
Recruiting
2
Phases
Phase 4
Conditions studied: GastritisDyspepsiaHelicobacter Pylori InfectionGastric CancerPeptic UlcerGastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
Yongquan Shi is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Yongquan Shi
How many clinical trials has Yongquan Shi sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Yongquan Shi, of which 2 are actively recruiting participants. These trials cover conditions including Gastritis, Dyspepsia, Helicobacter Pylori Infection. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Yongquan Shi research focus on?
Yongquan Shi clinical trials span Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Yongquan Shi clinical trial?
To participate in a Yongquan Shi trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Yongquan Shi trials with current recruitment status updated daily.
Clinical Trials by Yongquan Shi
NCT07139366 Phase 4
Recruiting
Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment
Gastritis
NCT07068607 Phase 4
Recruiting
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology